American’s Health Insurance Plans, a trade group representing health insurance companies that provide coverage to more than 200 million Americans, is calling for more stringent rules on approving and monitoring medical devices in light of a popular laparoscopic device that has become well-associated with the spread of uterine cancer, The Wall Street Journal reported on April 15.
In a letter addressed to U.S. Sen. Bob Casey, the group stressed how weak the FDA’s rules are when it comes to approving and monitoring medical devices on the market, including power morcellators. Power morcellators could spread unsuspecting cancer tissues during the removal of benign growths inside the uterus. The group further calls for the intensification of the 510(k) review process, which the group claims has been utterly lenient at monitoring low and moderate-risk medical devices.
If you believe your uterine cancer has resulted from a procedure involving a power morcellator, you might be qualified to seek compensation from the maker of the medical device. Speak with one of our lawyers at the National Injury Law Center by calling (888) 273-6041 today.